Video On-Demand: 

Monitoring Inflammation and Neurodegeneration in Multiple Sclerosis with Simoa® 

Sharel Figueredo, PhD -   Field Application Scientist, Quanterix


Please complete the form to access the video.

By submitting this form, you agree to Quanterix’s Terms of Use and Privacy Policy.  In addition, you agree to receive information regarding Quanterix products and services.  You will be able to unsubscribe at any time.

Follow Us!

  

Learn more about groundbreaking Simoa technology!

By enabling the detection of key neurodegenerative and inflammatory biomarkers with the greatest possible sensitivity, Simoa offers the tools that now allow researchers to see a more complete picture of MS, from early stages to treatment response.

Dr. Sharel Figueredo explains how Simoa enables precise measurements of protein biomarkers in blood and CSF, even when biomarker concentration is low. She also shares data from clinical trials in which Simoa was used to help accurately reflect inflammation and neuroaxonal injury.